Carregant...
Fitxers
Tipus de document
ArticleVersió
Versió publicadaData de publicació
Llicència de publicació
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/125949
The E3 ubiquitin ligase HERC1 controls the ERK signaling pathway targeting C-RAF for degradation
Títol de la revista
Director/Tutor
ISSN de la revista
Títol del volum
Recurs relacionat
Resum
The RAF/MEK/ERK cascade is a conserved intracellular signaling pathway that controls fundamental cellular processes including growth, proliferation, differentiation, survival and migration. Aberrant regulation of this signaling pathway has long been associated with human cancers. A major point of regulation of this pathway occurs at the level of the serine/threonine protein kinase C-RAF. Here, we show how the E3 ubiquitin ligase HERC1 regulates ERK signaling. HERC1 knockdown induced cellular proliferation, which is associated with an increase in ERK phosphorylation and in C-RAF protein levels. We demonstrate that overexpression of wild-type C-RAF is sufficient to increase ERK phosphorylation. Experiments with pharmacological inhibitors of RAF activity, or with interference RNA, show that the regulation of ERK phosphorylation by HERC1 is RAF-dependent. Immunoprecipitation, pull-down and confocal fluorescence microscopy experiments demonstrate an interaction between HERC1 and C-RAF proteins. Mechanistically, HERC1 controls C-RAF stability by regulating its polyubiquitylation in a lysine 48-linked chain. In vitro ubiquitylation assays indicate that C-RAF is a substrate of the E3 ubiquitin ligase HERC1. Altogether, we show how HERC1 can regulate cell proliferation through the activation of ERK signaling by a mechanism that affects C-RAF's stability.
Matèries (anglès)
Citació
Citació
SCHNEIDER, Taiane, MARTINEZ-MARTINEZ, Arturo, CUBILLOS ROJAS, Mónica, BARTRONS BACH, Ramon, VENTURA PUJOL, Francesc, ROSA LÓPEZ, José luis. The E3 ubiquitin ligase HERC1 controls the ERK signaling pathway targeting C-RAF for degradation. _Oncotarget_. 2018. Vol. 9, núm. 59, pàgs. 31531-31548. [consulta: 21 de gener de 2026]. ISSN: 1949-2553. [Disponible a: https://hdl.handle.net/2445/125949]